Phase 2 Extrahepatic Cholangiocarcinoma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Biliary Tract CancerCholangiocarcinomaExtrahepatic Cholangiocarcinoma+2 more

Beijing Biotech30 enrolled1 locationNCT07641036

Recruiting

Phase 2

Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Esophageal AdenocarcinomaGastric AdenocarcinomaPancreas Adenocarcinoma+6 more

Yale University54 enrolled1 locationNCT07282912

Recruiting

Phase 2

Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma

Extrahepatic CholangiocarcinomaUnresectable Perihilar or Ductal CCA

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest42 enrolled10 locationsNCT06440993